NASDAQ:HOLX

Hologic Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy HOLX

*Your capital is at risk

$76.01

+0 (+0%)

At Close: Jun 03, 2026

Hologic Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -56.40. In total, the insiders bought 352.91K and sold 1.52M HOLX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-56.40
● Buy	352.91K shares
● Sell	1.52M shares
8% Buy Activity Strong Negative Correlation
Sell Signal High Confidence Apr 07, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -56.4. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100. Supported by overwhelming sell-side pressure (8% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Schnittker Brandon President, Gyn Surgical	CEO / President	5 014 Value: $360.7K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Schnittker Brandon President, Gyn Surgical	CEO / President	3 865 Value: $287.4K
Apr 07, 2026 Sell	Common Stock D-Return	Schnittker Brandon President, Gyn Surgical	CEO / President	17 644 Value: $176
Apr 07, 2026 Sell	Performance Stock Units D-Return	Schnittker Brandon President, Gyn Surgical	CEO / President	8 432 Value: $0
Apr 07, 2026 Buy	Performance Stock Units A-Award	Schneiders Jennifer M President, Diag. Solutions	CEO / President	22 598 Value: $1.72M
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Schneiders Jennifer M President, Diag. Solutions	CEO / President	18 698 Value: $1.48M
Apr 07, 2026 Sell	Common Stock D-Return	Schneiders Jennifer M President, Diag. Solutions	CEO / President	41 462 Value: $415
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Schneiders Jennifer M President, Diag. Solutions	CEO / President	4 058 Value: $301.7K
Apr 07, 2026 Sell	Performance Stock Units D-Return	Schneiders Jennifer M President, Diag. Solutions	CEO / President	22 598 Value: $0
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Oberton Karleen Marie Chief Financial Officer	C-Suite Officer	28 047 Value: $2.23M
Apr 07, 2026 Sell	Performance Stock Units D-Return	Oberton Karleen Marie Chief Financial Officer	C-Suite Officer	42 707 Value: $0
Apr 07, 2026 Sell	Common Stock D-Return	De Walt Diana SVP, Human Resources	Officer	7 603 Value: $76
Apr 07, 2026 Sell	Performance Stock Units D-Return	Horvath Mark W. President, Breast & Skeletal	CEO / President	7 762 Value: $0
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Horvath Mark W. President, Breast & Skeletal	CEO / President	2 844 Value: $185.5K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Horvath Mark W. President, Breast & Skeletal	CEO / President	3 505 Value: $278.3K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Horvath Mark W. President, Breast & Skeletal	CEO / President	3 509 Value: $252.4K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Horvath Mark W. President, Breast & Skeletal	CEO / President	2 899 Value: $215.5K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Stamoulis Christiana Director	Director	4 536 Value: $346.2K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Stamoulis Christiana Director	Director	4 210 Value: $330.4K
Apr 07, 2026 Sell	Common Stock D-Return	Mohtashami Nanaz Director	Director	7 371 Value: $74
Apr 07, 2026 Sell	Common Stock D-Return	Mitchell Essex D Chief Operating Officer	C-Suite Officer	77 694 Value: $777
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Mitchell Essex D Chief Operating Officer	C-Suite Officer	25 070 Value: $1.80M
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Mitchell Essex D Chief Operating Officer	C-Suite Officer	32 722 Value: $2.60M
Apr 07, 2026 Sell	Performance Stock Units D-Return	Mitchell Essex D Chief Operating Officer	C-Suite Officer	46 154 Value: $0
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Mitchell Essex D Chief Operating Officer	C-Suite Officer	11 596 Value: $862.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT HOLOGIC

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima vi...

Read Full Profile Here